TY - JOUR T1 - CoViD-19 Epidemic in India and Projections: Is Relief in Sight? JF - medRxiv DO - 10.1101/2020.05.08.20096008 SP - 2020.05.08.20096008 AU - Abhaya Indrayan AU - Shubham Shukla Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/13/2020.05.08.20096008.abstract N2 - Background Projection of cases and deaths in an epidemic such as CoViD-19 is hazardous and the early projections were way-off the actual pattern. However, we now have actual data for more than 50 consecutive days in India that can be effectively used for projection.Methods We closely track the trend and use the same pattern for projection. We call this Empirical Model. We also fit a Theoretical Model based on a Gamma function on the pattern of some of the previous epidemics.Results The Empirical Model predicts the peak around the fourth week of May and the near end of the epidemic by the end of June 2020. The maximum number of active cases is likely to be nearly 75,000 during the second week of June. This would mean a peak demand of nearly 15,000 beds and nearly 4000 ventilators. The case-fatality based on those who have reached an outcome was nearly 10% in the first week of May and is likely to remain at this level for some time. Theoretical Model projected a peak of nearly 2500 new cases per day in the second week of May that seems to have been already breached. This model predicts the near end of the epidemic by the middle of July 2020.Conclusion With the current trend, the end of the epidemic is in sight with relatively mild consequences in India compared with most other countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo Funding sourceAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData has been taken from covid19india.org ER -